U.S. Markets
CVS Health (CVS) enhances its direct-to-consumer weight management offerings to improve access, affordability, care and support for GLP-1 medications
StockNow breaking-news AI analysis
CVS Health expanded its GLP-1 weight management program on August 5, 2026, offering $49 virtual visits and lower costs to drive retail traffic and improve long-term treatment adherence.
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
